Rafael Holdings, Inc. has announced a planned merger with Rafael Pharmaceuticals to create a publicly traded, late-stage cancer metabolism therapeutics company.

Rafael Holdings invests in novel cancer therapeutics that have the potential to improve and extend the lives of patients

Rafael Holdings invests in novel cancer therapeutics that have the potential to improve and extend the lives of patients.

News

Press Release
News Coverage